Related Experiment Video
Updated: Apr 12, 2026

05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
2.6K
Armenian bole: a historical medicinal clay
Pharmaceutical Historian
|May 14, 2015
Summary
Ancient healing clays, like Armenian bole, show therapeutic potential. Modern analysis can validate traditional uses, supporting their return to pharmacopeias for new pharmaceutical applications.
Area of Science:
- Geochemistry
- Pharmacology
- Medical History
Background:
- Traditional medicine extensively utilized earths and minerals, with specific clays still employed globally for therapeutic purposes.
- Historically popular medicaments lacking known pharmacological activity were removed from pharmacopeias, despite patient trust.
- Modern analytical techniques offer opportunities to re-evaluate these traditional compounds.
Observation:
- Healing clays possess scientifically validated therapeutic properties.
- Research over the past two decades has elucidated the active components and pharmacological actions of various clays.
- Armenian bole, a specific type of clay, has a documented history of therapeutic use across different cultures.
Findings:
- X-ray diffraction analysis was performed on a market-available sample of Armenian bole from Iran.
- The study investigated the historical therapeutic applications of Armenian bole globally.
- The chemical composition of the analyzed Armenian bole sample was determined.
Implications:
- Historical knowledge of traditional remedies can serve as a foundation for contemporary clinical and pharmacological research.
- Healing clays with proven therapeutic benefits could be reintegrated into modern medicine via pharmaceutical dosage forms.
- Further research into compounds like Armenian bole may uncover new therapeutic applications.
Related Concept Videos
One-Compartment Open Model for IV Bolus Administration: General Considerations
998
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
998
Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Two-Compartment Open Model: IV Bolus Administration
1.4K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
1.4K
Drug Delivery: Enteral Route
2.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
2.7K
Routes of Drug Administration: Enteral
8.5K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
8.5K
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
405
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
405

